Fermer le menu


Member of Lyonbiopole


Fab’entech is a privately owned biopharmaceutical SME developing immunotherapies to address situations of emergency. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease.


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide

Created on june 3rd, 2009 - 39 employees



24, rue Jean Baldassini 69007 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.